Innovative Technology Noah Medical has developed the Galaxy System, a fully image-integrated robotic platform for navigated bronchoscopy, showcasing advanced medical robotics capabilities designed to improve diagnostic accuracy and treatment outcomes.

Strong Funding & Growth With recent Series A and B funding rounds totaling $150 million and a revenue estimate between $50 million and $100 million, Noah Medical demonstrates substantial financial backing and potential for continued expansion in the medical robotics market.

Market Recognition The company has received multiple industry awards and recognition, including finalist positions in the Fierce Innovation Awards and Medtech Breakthrough awards, indicating a strong market reputation and validation of its innovative solutions.

Strategic Market Positioning Headquartered in Silicon Valley with a talented team of over 70 engineers and industry leaders, Noah Medical is well-positioned to capitalize on technological advancements and connect with healthcare providers seeking cutting-edge robotic diagnostic tools.

Expanding Clinical Adoption Having recently launched FDA clearance for its Galaxy System, Noah Medical is now positioned to accelerate adoption within U.S. healthcare institutions looking to upgrade their minimally invasive procedures with innovative robotic solutions.